Research Ins]i[ghts: Cardiac Safety Symposium 2021
Don't miss this 2-day interactive online event where the experts will be discussing current challenges in safety pharmacology and cardiac physiology, in silico modeling and best practices and evolvements of safety pharmacology methods.
See full agenda here.
Register now to learn more about:
- From iPSC banking to drug development and cardiac safety
- Advanced cardiac contractility assessments
- The use of stem cell cardiomyocyte models in predicting clinical cardiac endpoints
Yasunari Kanda, PhD
National Institute of Health Sciences, Japan
Michael K Pugsley, PhD, FBPhS, DSP
Director, Toxicology, Cytokinetics